212 related articles for article (PubMed ID: 33944659)
21. CC-Chemokine receptor CCR7: a key molecule for lymph node metastasis in esophageal squamous cell carcinoma.
Irino T; Takeuchi H; Matsuda S; Saikawa Y; Kawakubo H; Wada N; Takahashi T; Nakamura R; Fukuda K; Omori T; Kitagawa Y
BMC Cancer; 2014 Apr; 14():291. PubMed ID: 24766770
[TBL] [Abstract][Full Text] [Related]
22. p66Shc deficiency enhances CXCR4 and CCR7 recycling in CLL B cells by facilitating their dephosphorylation-dependent release from β-arrestin at early endosomes.
Patrussi L; Capitani N; Cattaneo F; Manganaro N; Gamberucci A; Frezzato F; Martini V; Visentin A; Pelicci PG; D'Elios MM; Trentin L; Semenzato G; Baldari CT
Oncogene; 2018 Mar; 37(11):1534-1550. PubMed ID: 29326436
[TBL] [Abstract][Full Text] [Related]
23. Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination.
López-Giral S; Quintana NE; Cabrerizo M; Alfonso-Pérez M; Sala-Valdés M; De Soria VG; Fernández-Rañada JM; Fernández-Ruiz E; Muñoz C
J Leukoc Biol; 2004 Aug; 76(2):462-71. PubMed ID: 15155773
[TBL] [Abstract][Full Text] [Related]
24. Depletion of host CCR7(+) dendritic cells prevented donor T cell tissue tropism in anti-CD3-conditioned recipients.
He W; Racine JJ; Johnston HF; Li X; Li N; Cassady K; Liu C; Deng R; Martin P; Forman S; Zeng D
Biol Blood Marrow Transplant; 2014 Jul; 20(7):920-8. PubMed ID: 24691220
[TBL] [Abstract][Full Text] [Related]
25. Stimulation of cells from a non-invaded and an invaded lymph node with a HER-2+ tumor with peptides corresponding to T-cell epitopes E75 and G89 induced expansion of central memory cells (TCM) from the metastasis-negative lymph nodes.
Ko BK; Efferson CL; Kawano K; Kuerer HM; Sahin A; Murray JL; Ioannides CG
Int J Oncol; 2004 Jun; 24(6):1413-8. PubMed ID: 15138582
[TBL] [Abstract][Full Text] [Related]
26. PEG10 activation by co-stimulation of CXCR5 and CCR7 essentially contributes to resistance to apoptosis in CD19+CD34+ B cells from patients with B cell lineage acute and chronic lymphocytic leukemia.
Hu C; Xiong J; Zhang L; Huang B; Zhang Q; Li Q; Yang M; Wu Y; Wu Q; Shen Q; Gao Q; Zhang K; Sun Z; Liu J; Jin Y; Tan J
Cell Mol Immunol; 2004 Aug; 1(4):280-94. PubMed ID: 16225771
[TBL] [Abstract][Full Text] [Related]
27. Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches.
Hayden RE; Pratt G; Roberts C; Drayson MT; Bunce CM
Leuk Lymphoma; 2012 Apr; 53(4):537-49. PubMed ID: 21812539
[TBL] [Abstract][Full Text] [Related]
28. Chemokine receptors and stromal cells in the homing and homeostasis of chronic lymphocytic leukemia B cells.
Burger JA; Kipps TJ
Leuk Lymphoma; 2002 Mar; 43(3):461-6. PubMed ID: 12002747
[TBL] [Abstract][Full Text] [Related]
29. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.
Herishanu Y; Pérez-Galán P; Liu D; Biancotto A; Pittaluga S; Vire B; Gibellini F; Njuguna N; Lee E; Stennett L; Raghavachari N; Liu P; McCoy JP; Raffeld M; Stetler-Stevenson M; Yuan C; Sherry R; Arthur DC; Maric I; White T; Marti GE; Munson P; Wilson WH; Wiestner A
Blood; 2011 Jan; 117(2):563-74. PubMed ID: 20940416
[TBL] [Abstract][Full Text] [Related]
30. Phenotype and immune function of lymph node and peripheral blood CLL cells are linked to transendothelial migration.
Pasikowska M; Walsby E; Apollonio B; Cuthill K; Phillips E; Coulter E; Longhi MS; Ma Y; Yallop D; Barber LD; Patten P; Fegan C; Ramsay AG; Pepper C; Devereux S; Buggins AG
Blood; 2016 Jul; 128(4):563-73. PubMed ID: 27252234
[TBL] [Abstract][Full Text] [Related]
31. CCR7 in Blood Cancers - Review of Its Pathophysiological Roles and the Potential as a Therapeutic Target.
Cuesta-Mateos C; Terrón F; Herling M
Front Oncol; 2021; 11():736758. PubMed ID: 34778050
[TBL] [Abstract][Full Text] [Related]
32. Ibrutinib Does Not Impact CCR7-Mediated Homeostatic Migration in T-Cells from Chronic Lymphocytic Leukemia Patients.
Mateu-Albero T; Marcos-Jimenez A; Wissmann S; Loscertales J; Terrón F; Stein JV; Muñoz-Calleja C; Cuesta-Mateos C
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681706
[TBL] [Abstract][Full Text] [Related]
33. The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization.
Hoellenriegel J; Zboralski D; Maasch C; Rosin NY; Wierda WG; Keating MJ; Kruschinski A; Burger JA
Blood; 2014 Feb; 123(7):1032-9. PubMed ID: 24277076
[TBL] [Abstract][Full Text] [Related]
34. Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow.
Hartmann TN; Grabovsky V; Wang W; Desch P; Rubenzer G; Wollner S; Binsky I; Vallon-Eberhard A; Sapoznikov A; Burger M; Shachar I; Haran M; Honczarenko M; Greil R; Alon R
Cancer Res; 2009 Apr; 69(7):3121-30. PubMed ID: 19293181
[TBL] [Abstract][Full Text] [Related]
35. The Human CD38 Monoclonal Antibody Daratumumab Shows Antitumor Activity and Hampers Leukemia-Microenvironment Interactions in Chronic Lymphocytic Leukemia.
Matas-Céspedes A; Vidal-Crespo A; Rodriguez V; Villamor N; Delgado J; Giné E; Roca-Ho H; Menéndez P; Campo E; López-Guillermo A; Colomer D; Roué G; Wiestner A; Parren PW; Doshi P; van Bueren JL; Pérez-Galán P
Clin Cancer Res; 2017 Mar; 23(6):1493-1505. PubMed ID: 27637890
[No Abstract] [Full Text] [Related]
36. Comparison of the in vitro effects of the anti-CD20 antibodies rituximab and GA101 on chronic lymphocytic leukaemia cells.
Patz M; Isaeva P; Forcob N; Müller B; Frenzel LP; Wendtner CM; Klein C; Umana P; Hallek M; Krause G
Br J Haematol; 2011 Feb; 152(3):295-306. PubMed ID: 21155758
[TBL] [Abstract][Full Text] [Related]
37. Association between the expression of chemokine receptors CCR7 and CXCR3, and lymph node metastatic potential in lung adenocarcinoma.
Maekawa S; Iwasaki A; Shirakusa T; Kawakami T; Yanagisawa J; Tanaka T; Shibaguchi H; Kinugasa T; Kuroki M; Kuroki M
Oncol Rep; 2008 Jun; 19(6):1461-8. PubMed ID: 18497951
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of CC-chemokine receptor seven expression in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor.
Xia Y; Liu L; Xiong Y; Bai Q; Wang J; Xi W; Qu Y; Xu J; Guo J
BMC Cancer; 2017 Jan; 17(1):70. PubMed ID: 28114889
[TBL] [Abstract][Full Text] [Related]
39. RhoH is critical for cell-microenvironment interactions in chronic lymphocytic leukemia in mice and humans.
Troeger A; Johnson AJ; Wood J; Blum WG; Andritsos LA; Byrd JC; Williams DA
Blood; 2012 May; 119(20):4708-18. PubMed ID: 22474251
[TBL] [Abstract][Full Text] [Related]
40. ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL).
Richardson SJ; Matthews C; Catherwood MA; Alexander HD; Carey BS; Farrugia J; Gardiner A; Mould S; Oscier D; Copplestone JA; Prentice AG
Blood; 2006 May; 107(9):3584-92. PubMed ID: 16332969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
